Investment

Features

Academy

Home/News Feed/BioNTech to release Q2 2026 results and host investor webcast on August 4, highlighting oncology progress.

BNTX

$116.57

+$5.68 +5.12%

BioNTech to release Q2 2026 results and host investor webcast on August 4, highlighting oncology progress.

Company Fundamentals

21 Jul 2026

View Source

Neutral

BioNTech SE will announce its second quarter 2026 financial results on August 4, 2026, followed by a webcast and conference call for investors and the public. The event will cover financial performance and updates on BioNTech's oncology pipeline, which includes innovative cancer therapies like immunomodulators, antibody-drug conjugates, and mRNA treatments. The company collaborates with major partners such as Pfizer and Bristol Myers Squibb, aiming to advance cancer treatment across various stages. This update is important for investors tracking BioNTech's growth in cancer therapies and its strategic partnerships.

More News (BNTX)

mRNA stocks swing wildly on melanoma trial news with no new data Friday

Moderna and BioNTech stocks experienced sharp volatility for a third day following a Phase 3 melanoma trial success involving Moderna's mRNA vaccine combined with Merck's Keytruda. Despite no new clinical data Friday, Moderna's shares surged 8%, cont...

Market News

Bullish

2 days ago